MRFRの分析によると、インドのジェネリック医薬品の市場規模は2023年に25.66 (10億ドル)と推定されました。 この市場は、2024年の27.5 (10億ドル)から2035年には90.0 (10億ドル)に成長し、予測期間 (2025年から2035年) の間のCAGRは約11.381%になると予想されます。
目次
Table of Contents
1. EXECUTIVE SUMMARY
1. Market Overview
2. Key Findings
3. Market Segmentation
4. Competitive Landscape
5. Challenges and Opportunities
6. Future Outlook
1. MARKET INTRODUCTION
1. Definition
2. Scope of the study
1. Research Objective
2. Assumption
3. Limitations
2. RESEARCH METHODOLOGY
1. Overview
2. Data Mining
3. Secondary Research
4. Primary Research
1. Primary Interviews and Information Gathering Process
2. Breakdown of Primary Respondents
5. Forecasting Model
6. Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
7. Data Triangulation
8. Validation
1. MARKET DYNAMICS
1. Overview
2. Drivers
3. Restraints
4. Opportunities
2. MARKET FACTOR ANALYSIS
1. Value chain Analysis
2. Porter's Five Forces Analysis
1. Bargaining Power of Suppliers
2. Bargaining Power of Buyers
3. Threat of New Entrants
4. Threat of Substitutes
5. Intensity of Rivalry
3. COVID-19 Impact Analysis
1. Market Impact Analysis
2. Regional Impact
3. Opportunity and Threat Analysis
1. India Generic Pharmaceuticals Market, BY Type (USD Billion)
1. Simple Generics
2. Specialty Generics
3. Biosimilars
2. India Generic Pharmaceuticals Market, BY Application (USD Billion)
1. Central Nervous System Disorders
2. Respiratory Diseases
3. Hormones Related Diseases
4. Gastrointestinal Diseases
5. Cardiovascular Diseases
6. Infectious Diseases
7. Cancer
8. Diabetes
9. Others
3. India Generic Pharmaceuticals Market, BY Product (USD Billion)
1. Small Molecule
2. Large Molecule
4. India Generic Pharmaceuticals Market, BY Route of Administration (USD Billion)
1. Oral
2. Injectable
3. Inhalable
4. Others
5. India Generic Pharmaceuticals Market, BY Distribution Channel (USD Billion)
1. Online Pharmacies
2. Retail Pharmacies
3. Hospital Pharmacies
1. Competitive Landscape
1. Overview
2. Competitive Analysis
3. Market share Analysis
4. Major Growth Strategy in the Generic Pharmaceuticals Market
5. Competitive Benchmarking
6. Leading Players in Terms of Number of Developments in the Generic Pharmaceuticals Market
7. Key developments and growth strategies
1. New Product Launch/Service Deployment
2. Merger Acquisitions
3. Joint Ventures
8. Major Players Financial Matrix
1. Sales and Operating Income
2. Major Players RD Expenditure. 2023
2. Company Profiles
1. Sangamo Therapeutics
1. Financial Overview
2. Products Offered
3. Key Developments
4. SWOT Analysis
5. Key Strategies
2. Sun Pharmaceutical Industries
1. Financial Overview
2. Products Offered
3. Key Developments
4. SWOT Analysis
5. Key Strategies
3. Torrent Pharmaceuticals
1. Financial Overview
2. Products Offered
3. Key Developments
4. SWOT Analysis
5. Key Strategies
4. Natco Pharma
1. Financial Overview
2. Products Offered
3. Key Developments
4. SWOT Analysis
5. Key Strategies
5. Zydus Cadila
1. Financial Overview
2. Products Offered
3. Key Developments
4. SWOT Analysis
5. Key Strategies
6. Cipla
1. Financial Overview
2. Products Offered
3. Key Developments
4. SWOT Analysis
5. Key Strategies
7. Aurobindo Pharma
1. Financial Overview
2. Products Offered
3. Key Developments
4. SWOT Analysis
5. Key Strategies
8. Alkem Laboratories
1. Financial Overview
2. Products Offered
3. Key Developments
4. SWOT Analysis
5. Key Strategies
9. GlaxoSmithKline Pharmaceuticals
1. Financial Overview
2. Products Offered
3. Key Developments
4. SWOT Analysis
5. Key Strategies
10. Himalaya Drug Company
1. Financial Overview
2. Products Offered
3. Key Developments
4. SWOT Analysis
5. Key Strategies
11. Biocon
1. Financial Overview
2. Products Offered
3. Key Developments
4. SWOT Analysis
5. Key Strategies
12. Dr. Reddy's Laboratories
1. Financial Overview
2. Products Offered
3. Key Developments
4. SWOT Analysis
5. Key Strategies
13. Lupin
1. Financial Overview
2. Products Offered
3. Key Developments
4. SWOT Analysis
5. Key Strategies
14. Wockhardt
1. Financial Overview
2. Products Offered
3. Key Developments
4. SWOT Analysis
5. Key Strategies
15. Mylan
1. Financial Overview
2. Products Offered
3. Key Developments
4. SWOT Analysis
5. Key Strategies
3. Appendix
1. References
2. Related Reports
LIST Of tables
1. LIST OF ASSUMPTIONS
2. India Generic Pharmaceuticals Market SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD Billions)
3. India Generic Pharmaceuticals Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
4. India Generic Pharmaceuticals Market SIZE ESTIMATES & FORECAST, BY PRODUCT, 2019-2035 (USD Billions)
5. India Generic Pharmaceuticals Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)
6. India Generic Pharmaceuticals Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)
7. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
8. ACQUISITION/PARTNERSHIP
LIST Of figures
1. MARKET SYNOPSIS
2. INDIA GENERIC PHARMACEUTICALS MARKET ANALYSIS BY TYPE
3. INDIA GENERIC PHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
4. INDIA GENERIC PHARMACEUTICALS MARKET ANALYSIS BY PRODUCT
5. INDIA GENERIC PHARMACEUTICALS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
6. INDIA GENERIC PHARMACEUTICALS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
7. KEY BUYING CRITERIA OF GENERIC PHARMACEUTICALS MARKET
8. RESEARCH PROCESS OF MRFR
9. DRO ANALYSIS OF GENERIC PHARMACEUTICALS MARKET
10. DRIVERS IMPACT ANALYSIS: GENERIC PHARMACEUTICALS MARKET
11. RESTRAINTS IMPACT ANALYSIS: GENERIC PHARMACEUTICALS MARKET
12. SUPPLY / VALUE CHAIN: GENERIC PHARMACEUTICALS MARKET
13. GENERIC PHARMACEUTICALS MARKET, BY TYPE, 2024 (% SHARE)
14. GENERIC PHARMACEUTICALS MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
15. GENERIC PHARMACEUTICALS MARKET, BY APPLICATION, 2024 (% SHARE)
16. GENERIC PHARMACEUTICALS MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
17. GENERIC PHARMACEUTICALS MARKET, BY PRODUCT, 2024 (% SHARE)
18. GENERIC PHARMACEUTICALS MARKET, BY PRODUCT, 2019 TO 2035 (USD Billions)
19. GENERIC PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
20. GENERIC PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019 TO 2035 (USD Billions)
21. GENERIC PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
22. GENERIC PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019 TO 2035 (USD Billions)
23. BENCHMARKING OF MAJOR COMPETITORS
